- Tytuł:
- A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non-small-cell lung cancer who have progressed after anti-PD-1/L1 therapy.
- Autorzy:
- Źródło:
- Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6855. Date of Electronic Publication: 2024 Jan 12.
- Typ publikacji:
- Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial
- MeSH Terms:
-
Antineoplastic Agents *
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized/adverse effects
Czasopismo naukowe